2024-04-15 10:55:50 ET
Summary
- CME Group's stock has underperformed the S&P 500 this year, but has significantly outperformed the market over the past decade.
- The company's diversification benefits, and low-capex characteristics, make it an attractive long-term investment, alongside being well positioned to capitalize from current macro uncertainty in geopolitics, monetary policy and commodities volatility.
- Its undervalued status compared to its multiple history, and aforementioned catalyst justify a buy rating to the stock.
Read the full article on Seeking Alpha
For further details see:
CME Group: Appealing business Characteristics That Could Benefit From Geopolitical Uncertainty